fasting periods of 24 hours
OtherPost-balloon occlusion procedure: fasting for 24 hours
NCT Number: NCT07774143
To evaluate the efficacy and safety of early postoperative oral intake (with a fasting period of 6 hours) versus delayed postoperative oral intake (with fasting periods of 24 hours or 48 hours) in patients with cirrhosis undergoing esophageal variceal ligation therapy.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
The Fifth People's Hospital of Anyang, Anyang, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-1. The patient must be aged>18 years; 2. The diagnosis of portal hypertension must be confirmed, with gastroscopy revealing severe esophageal varices and a positive red sign; 3. For patients undergoing endoscopic variceal ligation (EVL) due to esophageal varices (including those with hemorrhage or those eligible for elective ligation), successful intraoperative ligation is achieved (achieving hemostasis or completing the predetermined ligation procedure).
Exclusion criteria
Post-balloon occlusion procedure: fasting for 24 hours
Post-balloon occlusion procedure: fasting for 48 hours
Post-balloon occlusion procedure: fasting for 6 hours
Time frame: Week 0-6
Time frame: Week 0-4
Time frame: Week 0-4
Time frame: Week 0-4
Contact information is provided by the study sponsor or research team.
The First Affiliated Hospital of Zhengzhou University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07122622
Digestive System Diseases, Esophageal Diseases
Roma, Italia, Italy
View Trial DetailsNCT07163689
Digestive System Diseases, Esophageal Diseases
Amiens, Picardie, France
View Trial DetailsNCT06970509
Digestive System Diseases, Esophageal Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT06908798
Digestive System Diseases, Esophageal Diseases
Tanta, Gharbyea, Egypt
View Trial Details